{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:02:57Z","timestamp":1740135777746,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00380-021-01934-8","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T19:28:50Z","timestamp":1630697330000},"page":"434-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of oral tolvaptan for 1 year in patients with functional mitral regurgitation"],"prefix":"10.1007","volume":"37","author":[{"given":"Fukuko","family":"Nagura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1857-709X","authenticated-orcid":false,"given":"Akihisa","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruri","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Hioki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanari","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoko","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kozuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"key":"1934_CR1","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Frederick A, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WW, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147-239","journal-title":"J Am Coll Cardiol"},{"key":"1934_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1253\/circj.72.489","volume":"72","author":"Y Okura","year":"2008","unstructured":"Okura Y, Ramadan MM, Ohno Y, Mitsuma W, Tanaka K, Ito M, Suzuki K, Tanabe N, Kodama M, Aizawa Y (2008) Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J 72:489\u2013491","journal-title":"Circ J"},{"key":"1934_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/eurheartj\/ehx402","volume":"39","author":"G Goliasch","year":"2018","unstructured":"Goliasch G, Bartko PE, Pavo N, Neuhold S, Wurm R, Mascherbauer J, Lang IM, Strunk G, H\u00fclsmann M (2018) Refining the prognostic impact of functional mitral regurgitation in chronic heart failure. Eur Heart J 39:39\u201346","journal-title":"Eur Heart J"},{"key":"1934_CR4","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1136\/hrt.2011.225789","volume":"97","author":"A Rossi","year":"2011","unstructured":"Rossi A, Dini FL, Faggiano P, Agricola P, Cicoira M, Frattini S, Simioniuc A, Gullace M, Ghio S, Enriquez-Sarano M, Temporelli PL (2011) Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 97:1675\u20131680","journal-title":"Heart"},{"key":"1934_CR5","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jacc.2011.06.032","volume":"58","author":"ZM Gertz","year":"2011","unstructured":"Gertz ZM, Raina A, Saghy L, Zado ES, Callans DJ, Marchlinski FE, Keane MG, Silvestry FE (2011) Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol 58:1474\u20131481","journal-title":"J Am Coll Cardiol"},{"key":"1934_CR6","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","volume":"103","author":"F Grigioni","year":"2001","unstructured":"Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ (2001) Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103:1759\u20131764","journal-title":"Circulation"},{"key":"1934_CR7","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","volume":"297","author":"M Gheorghiade","year":"2007","unstructured":"Gheorghiade M, Konstam MA, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C (2007) Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 297:1332\u20131343","journal-title":"JAMA"},{"issue":"Suppl 1","key":"1934_CR8","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1007\/s10557-011-6304-x","volume":"25","author":"M Matsuzaki","year":"2011","unstructured":"Matsuzaki M, Hori M, Izumi T, Fukunami M, T Investigators (2011) Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study). Cardiovasc Drugs Ther 25(Suppl 1):S33-45","journal-title":"Cardiovasc Drugs Ther"},{"key":"1934_CR9","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s00380-019-01411-3","volume":"34","author":"M Mitsui","year":"2019","unstructured":"Mitsui M, Kataoka A, Nara Y, Nagura F, Kawashima H, Hioki H, Nakashima M, Watanabe Y, Yokoyama N, Kozuma K (2019) Clinical safety and efficacy of tolvaptan for acute phase therapy in patients with low-flow and normal-flow severe aortic stenosis. Heart Vessels 34:1684\u20131691","journal-title":"Heart Vessels"},{"key":"1934_CR10","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa040532","volume":"351","author":"LA Pi\u00e9rard","year":"2004","unstructured":"Pi\u00e9rard LA, Lancellotti P (2004) The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 351:1627\u20131634","journal-title":"N Engl J Med"},{"key":"1934_CR11","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"MA Konstam","year":"2007","unstructured":"Konstam MA, Gheorghiade M, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C, Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297:1319\u20131331","journal-title":"JAMA"},{"key":"1934_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207481","volume":"13","author":"H Takimura","year":"2018","unstructured":"Takimura H, Hada T, Kawano M, Yabe T, Takimura Y, Nishio S, Nakano M, Tsukahara R, Muramatsu T (2018) A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan. PLoS ONE 13:e0207481","journal-title":"PLoS ONE"},{"key":"1934_CR13","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00380-015-0775-9","volume":"31","author":"Y Uemura","year":"2016","unstructured":"Uemura Y, Shibata R, Takemoto K, Uchikawa T, Koyasu M, Ishikawa S, Mitsuda T, Miura A, Imai R, Iwamiya S, Ozaki Y, Kato T, Miura T, Watarai M, Murohara T (2016) Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease. Heart Vessels 31:1643\u20131649","journal-title":"Heart Vessels"},{"key":"1934_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1536\/ihj.16-023","volume":"57","author":"T Imamura","year":"2016","unstructured":"Imamura T, Kinugawa K (2016) Tolvaptan improves the long-term prognosis in patients with congestive heart failure with preserved ejection fraction as well as in those with reduced ejection fraction. Int Heart J 57:600\u2013606","journal-title":"Int Heart J"},{"key":"1934_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00380-018-1290-6","volume":"34","author":"K Matsumura","year":"2019","unstructured":"Matsumura K, Morishita S, Taniguchi N, Takehana K, Takahashi H, Otagaki M, Yoshioka K, Yamamoto Y, Takagi M, Shiojima I (2019) Prognostic factors for long term outcomes in acute decompensated heart failure patients under tolvaptan treatment. Heart Vessels 34:607\u2013615","journal-title":"Heart Vessels"},{"key":"1934_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","volume":"30","author":"WA Zoghbi","year":"2017","unstructured":"Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ (2017) Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 30:303\u2013371","journal-title":"J Am Soc Echocardiogr"},{"key":"1934_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/ehjci\/jet105","volume":"14","author":"P Lancellotti","year":"2013","unstructured":"Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL, Scientific Document Committee of the European Association of Cardiovascular Imaging (2013) Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 14:611\u2013644","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1934_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jcmg.2018.11.006","volume":"12","author":"PA Grayburn","year":"2019","unstructured":"Grayburn PA, Sannino A, Packer M (2019) Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging 12:353\u2013362","journal-title":"JACC Cardiovasc Imaging"},{"key":"1934_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1517\/14656566.2011.567267","volume":"12","author":"A Ambrosy","year":"2011","unstructured":"Ambrosy A, Goldsmith SR, Gheorghiade M (2011) Tolvaptan for the treatment of heart failure: a review of the literature. Expert Opin Pharmacother 12:961\u2013976","journal-title":"Expert Opin Pharmacother"},{"key":"1934_CR20","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1253\/circj.CJ-14-0592","volume":"78","author":"K Dohi","year":"2014","unstructured":"Dohi K, Ito M (2014) Novel diuretic strategies for the treatment of heart failure in Japan. Circ J 78:1816\u20131823","journal-title":"Circ J"},{"key":"1934_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/CIRCHEARTFAILURE.113.000828","volume":"7","author":"SR Goldsmith","year":"2014","unstructured":"Goldsmith SR, Bart BA, Burnett J (2014) Decongestive therapy and renal function in acute heart failure: time for a new approach? Circ Heart Fail 7:531\u2013535","journal-title":"Circ Heart Fail"},{"key":"1934_CR22","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","volume":"63","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwinlll JP, Guyton RA, O\u2019Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundtlll TM, Thomas JD (2014) AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:e57-185","journal-title":"J Am Coll Cardiol"},{"key":"1934_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ehf2.12042","volume":"2","author":"Z He","year":"2015","unstructured":"He Z, Sun Y, Gao H, Zhang J, Lu Y, Feng J, Su H, Zeng C, Lv A, Cheng K, Li Y, Huan Li H, Luan R, Wang L, Yu Q (2015) Efficacy and safety of supramaximal titrated inhibition of renin-angiotensin-aldosterone system in idiopathic dilated cardiomyopathy. ESC Heart Failure 2:129\u2013138","journal-title":"ESC Heart Failure"},{"key":"1934_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/hrt.72.1.63","volume":"72","author":"B Seneviratne","year":"1994","unstructured":"Seneviratne B, Moore GA, West PD (1994) Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial. Br Heart J 72:63\u201368","journal-title":"Br Heart J"},{"key":"1934_CR25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1388-9842(03)00105-3","volume":"5","author":"F Waagstein","year":"2003","unstructured":"Waagstein F, Stromblad O, Andersson B, Bohm M, Darius M, Delius W, Goss F, Osterziel KJ, Sigmund M, Trenkwalder SP, Wahlqvist L (2003) Increased exercise ejection Fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy. Eur J Heart Fail 5:679\u2013691","journal-title":"Eur J Heart Fail"},{"key":"1934_CR26","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S0002-9149(99)00059-4","volume":"83","author":"BD Lowes","year":"1999","unstructured":"Lowes BD, Gill EA, Abraham WT, Larrain JR, Robertson AD, Bristow MR, Gilbert EM (1999) Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 83:1201\u20131205","journal-title":"Am J Cardiol"},{"key":"1934_CR27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.119.039612","volume":"140","author":"M Packer","year":"2019","unstructured":"Packer M, Grayburn PA (2019) Contrasting effects of pharmacological, procedural, and surgical interventions on proportionate and disproportionate functional mitral regurgitation in chronic heart failure. Circulation 140:779\u2013789","journal-title":"Circulation"},{"issue":"Suppl 1","key":"1934_CR28","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1007\/s10557-011-6350-4","volume":"25","author":"T Onogawa","year":"2011","unstructured":"Onogawa T, Sakamoto Y, Nakamura S, Nakayama S, Fujiki H, Yamamura Y (2011) Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure. Cardiovasc Drugs Ther 25(Suppl 1):S67-76","journal-title":"Cardiovasc Drugs Ther"},{"key":"1934_CR29","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ, COAPT Investigators (2018) Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379:2307\u20132318","journal-title":"N Engl J Med"},{"key":"1934_CR30","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, Meer PV, Authors\/Task Force Members; Document Reviewers (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129\u20132200","journal-title":"Eur Heart J"},{"key":"1934_CR31","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","volume":"83","author":"H Tsutsui","year":"2019","unstructured":"Tsutsui H, Isobe M, Ito H, Okumura K, Ono M, Kitakaze M, Kinugawa K, Kihara Y, Goto Y, Komuro I, Saiki Y, Saito Y, Sakata Y, Sato N, Sawa Y, Shiose A, Shimizu W, Shimokawa H, Seino Y, Node K, Higo T, Hirayama A, Makaya M, Masuyama T, Murohara T, Momomura S, Yano M, Yamazaki K, Yamamoto K, Yoshikawa T, Yoshimura M, Akiyama M, Anzai T, Ishihara S, Inomata T, Imamura T, Iwasaki Y, Ohtani T, Onishi K, Kasai T, Kato M, Kawai M, Kinugasa Y, Kinugawa S, Kuratani T, Kobayashi S, Sakata Y, Tanaka A, Toda K, Noda T, Nochioka K, Hatano M, Hidaka T, Fujino T, Makita S, Yamaguchi O, Ikeda U, Kimura T, Kohsaka S, Kosuge M, Yamagishi M, Yamashina A, A Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group (2019) JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure- digest version. Circ J 83:2084\u20132184","journal-title":"Circ J"},{"key":"1934_CR32","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2007.11.085","volume":"51","author":"M Nishii","year":"2008","unstructured":"Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T (2008) Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure. J Am Coll Cardiol 51:2329\u20132335","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-021-01934-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-021-01934-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-021-01934-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T16:04:46Z","timestamp":1644595486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-021-01934-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1934"],"URL":"https:\/\/doi.org\/10.1007\/s00380-021-01934-8","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"type":"print","value":"0910-8327"},{"type":"electronic","value":"1615-2573"}],"subject":[],"published":{"date-parts":[[2021,9,2]]},"assertion":[{"value":"13 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kiyoko Uno was an employee of Sanofi before joining this study. Other authors declare no relationships with industry or other entities with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}